Generic Oncology Drugs Market Report: Analysis and Forecast to 2028 with US$ 37.1 Billion Valuation | IMARC Group
How Big is the Generic Oncology Drugs Market? According to IMARC Group’s latest report, titled “ Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 .’ the global generic oncology drugs market size reached US$ 27.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2023-2028. Request for a PDF Sample of this Report: https://www.imarcgroup.com/generic-oncology-drug-manufacturing-plant/requestsample What is Generic Oncology drugs ? Generic oncology drugs share the same active ingredients and are less costly than their branded non-biological counterparts. These drugs can be oral, intravenous, intramuscular, topical, or inhalant. Generic oncology drugs are similar to brand-name cancer care medications in terms of dosage, form, quality, strength, route of administration, performance characteristics, and intended use. They effec...